Medical/Pharmaceuticals

Hummingbird Bioscience Appoints Jan Møller Mikkelsen as Chairman of the Board

HOUSTON and SINGAPORE, Nov. 29, 2021 /PRNewswire/ -- Hummingbird Bioscience Holdings Limited, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets in cancer and autoimmune disease, today announced the appointment of Jan Møller Mikkels...

2021-11-29 17:00 1755

Ablaze Pharmaceuticals Launches with $75m Series A Financing to Bring Novel Targeted Radiopharmaceuticals to Treat Cancer Patients in the Greater China Market

SHANGHAI and SAN DIEGO, Nov. 29, 2021 /PRNewswire/ -- Ablaze Pharmaceuticals ("Ablaze"), a clinical-stage pharmaceutical company focused on the development and commercialization of innovative targeted radiopharmaceutical therapies (TRT) against tumor targets, announced a$75 million Series A finan...

2021-11-29 10:00 3415

VISTA Eye Specialist Shares How It Thrives during the COVID-19 Pandemic

PETALING JAYA, Malaysia, Nov. 29, 2021 /PRNewswire/ -- As part of VISTA Eye Specialists' (VISTA) core value of 'Giving Back to the Community', VISTA does not only give for charity, but believes strongly in sharing of knowledge and experiences. Other than sharing via conferences and publications, ...

2021-11-29 09:40 2151

Tang Prize Laureates Reflect on the Breakthroughs Made Possible by Cytokine Research

TAIPEI, Nov. 27, 2021 /PRNewswire/ -- Following the inspiring opening speech, "Future Perspective of Cancer Immunotherapy," delivered by Nobel Prize and Tang Prize laureate Prof.Tasuku Honjo at the 14th Asia Pacific Federation of Pharmacologist Conference (APFP) onNovember 26, the 2020 Tang Prize...

2021-11-27 16:00 4617

ASUS and Medical Professionals Showcase Five Smart Healthcare Achievements

SINGAPORE, Nov. 26, 2021 /PRNewswire/ -- ASUS Intelligent Cloud Services (AICS) today introduced five smart medical solutions during its AICS Medical Open House. The xHIS platform, the Lumos EMR search platform, the Drug Safety Service, the Miraico smart medical coding assistant and the Personal ...

2021-11-26 21:47 5192

Australian biotech company Starpharma announces positive interim results from the prostate cancer cohort in its ongoing phase 2 trial of DEP® cabazitaxel

MELBOURNE, Australia, Nov. 26, 2021 /PRNewswire/ -- Starpharma showed that 100% of evaluable patients with Stage IV prostate cancer have had efficacy responses, utilising one or more standard measures of disease. DEP® cabazitaxel  is a patent...

2021-11-26 17:34 2707

Róbert Wessman-led Aztiq and Innobic join forces in $475m acquisition of Lotus Pharmaceutical and Adalvo to create a global pharmaceutical powerhouse

REYKJAVÍK, Iceland, Nov. 26, 2021 /PRNewswire/ -- Aztiq   ("Aztiq"), a healthcare investor led by Alvogen Founder and Chairman Róbert Wessman, andInnobic (Asia) Company Limited ("Innobic"), a life sciences subsi...

2021-11-26 15:51 2452

Starpharma releases positive DEP® phase 2 interim results in prostate cancer

MELBOURNE, Australia, Nov. 26, 2021 /PRNewswire/ -- Melbourne biotech company Starpharma today announced positive interim results from the prostate cancer cohort in its ongoing phase 2 trial of DEP® cabazitaxel. The company showed that 100% of evaluable patients with (Stage IV) metastatic prostat...

2021-11-26 15:41 2030

Premium Red Ginseng Brand CheongKwanJang to Celebrate 122nd anniversary

SEOUL, South Korea, Nov. 26, 2021 /PRNewswire/ -- Korea Ginseng Corp (KGC) celebrates the 122nd anniversary of its premium red ginseng brand, CheongKwanJang. Red Ginseng One of the best ginseng in the world, Korean ginseng became a premi...

2021-11-26 15:37 2800

Premium Red Ginseng Brand CheongKwanJang to Celebrate 122nd anniversary

SEOUL, South Korea, Nov. 26, 2021 /PRNewswire/ -- Korea Ginseng Corp (KGC) celebrates the 122nd anniversary of its premium red ginseng brand, CheongKwanJang. Korean Ginseng One of the best ginseng in the world, Korean ginseng became a...

2021-11-26 15:28 3093

Antengene Included in the MSCI Global Small Cap Indexes - MSCI China Index Constituent Stocks

SHANGHAI and HONG KONG, Nov. 26, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and onco...

2021-11-26 11:34 3669

Medical AI Provider Lunit Raises $61M in Funding Round Led By Major Global Healthcare Investors

- New investors include US life science investors HealthQuest Capital, Casdin Capital, and American Cancer Society BrightEdge, andAsia-based global healthcare investors Tybourne Capital Management and NSG Ventures - Following the most recent strategic investment of $26 million from Guardant Heal...

2021-11-25 22:00 3135

How CIIE offers a window for multinational companies into the Chinese market

SHANGHAI, Nov. 25, 2021 /PRNewswire/ -- Opening up is the hallmark of contemporaryChina. The China International Import Expo (CIIE) is poised to shape a link betweenChina and the global market.   Scheduled from Nov 5 to 10, the 4th CIIE presented a total of 422 new products, technologies, and s...

2021-11-25 18:37 3017

Henlius Novel Anti PD-L1/TIGIT Bispecific Antibody Received Clinical Trial Approval in Australia

SHANGHAI, Nov. 25, 2021 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the filing of a clinical trial for HLX301, a Recombinant Humanized Anti-PDL1 and Anti-TIGIT Bispecific Antibody, in Patients with locally advanced or metastatic solid tumours has been approved by the ...

2021-11-25 17:27 2951

More cancer patients in Africa to benefit from advanced radiation therapy with Elekta Unity MR-Linac

STOCKHOLM, Nov. 25, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that its latest African order for Elekta Unity MR-Linac comes less than six months after the company introduced its ACCESS 2025 strategy, which includes giving more than 300 million people access to radiation therapy with...

2021-11-25 17:06 1761

Elekta: Interim report, May-October 2021/22

STOCKHOLM, Nov. 25, 2021 /PRNewswire/ -- The increasing need for investments in cancer care and radiotherapy across the globe supported a gradual market recovery during the quarter. Our orders grew with double digits, and despite the continued global supply chain challenges we secured good revenu...

2021-11-25 16:48 2069

Innovative €250,000 Parenteral Nutrition Research Grant Awarded by Fresenius Kabi

BAD HOMBURG, Germany, Nov. 25, 2021 /PRNewswire/ -- Fresenius Kabi was delighted to announce the winner of their innovative JUMPstart education program and research grant onSeptember 10, 2021. JUMPstart is an initiative that aims to nurture research in the field of parenteral nutrition through th...

2021-11-25 15:45 2642

Sartorius significantly expands activities in South Korea

SHANGHAI, Nov. 25, 2021 /PRNewswire/ -- The life science company Sartorius is investing around270 million euros, some 300 million U.S. dollars, through the end of 2024 in expanding its activities inSouth Korea. In the country's biopharma hub Songdo in Incheon, the company plans to launch cell cul...

2021-11-25 12:42 1813

USANA Assists Philippine Basketball Association As Nutritional Partner

USANA Named The Official Nutritional Supplements of the PBA SALT LAKE CITY, Nov. 25, 2021 /PRNewswire/ -- As USANA, the Cellular Nutrition Company, looks to its 30th anniversary next spring, it continues to showcase and build its elite and diverse athletic partnerships. For more than two decades...

2021-11-25 06:17 2654

Global Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2022

Added 19,066 New Subscribers in 2Q22 Revenues Up 9.8% YoY to RMB313.7 Million ($48.7 Million)         Gross Profit Up 11.0% YoY to RMB267.5 Million ($41.5 Million) Operating Income Up 15.3% YoY to RMB160.5 Million ($24.9 Million) Non-GAAP Operating Income Up 14.1% YoY to RMB172.8 Million ($26.8 Mi...

2021-11-25 05:16 3738
1 ... 190191192193194195196 ... 382